Cargando…
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
Advances in research have boosted therapy development for congenital disorders of glycosylation (CDG), a group of rare genetic disorders affecting protein and lipid glycosylation and glycosylphosphatidylinositol anchor biosynthesis. The (re)use of known drugs for novel medical purposes, known as dru...
Autores principales: | Brasil, Sandra, Allocca, Mariateresa, Magrinho, Salvador C. M., Santos, Inês, Raposo, Madalena, Francisco, Rita, Pascoal, Carlota, Martins, Tiago, Videira, Paula A., Pereira, Florbela, Andreotti, Giuseppina, Jaeken, Jaak, Kantautas, Kristin A., Perlstein, Ethan O., Ferreira, Vanessa dos Reis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369176/ https://www.ncbi.nlm.nih.gov/pubmed/35955863 http://dx.doi.org/10.3390/ijms23158725 |
Ejemplares similares
-
Congenital disorders of glycosylation (CDG): state of the art in 2022
por: Francisco, Rita, et al.
Publicado: (2023) -
CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018) -
New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
por: Francisco, Rita, et al.
Publicado: (2020) -
How to find and diagnose a CDG due to defective N-glycosylation
por: Lefeber, Dirk J., et al.
Publicado: (2011) -
The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)
por: Francisco, Rita, et al.
Publicado: (2022)